| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2350 |
Injection, ocrelizumab, 1 mg |
18 |
12 |
$569K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
150 |
109 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
42 |
38 |
$2K |
| 96415 |
|
42 |
25 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
78 |
49 |
$887.39 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
55 |
38 |
$773.30 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
20 |
13 |
$631.40 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
12 |
12 |
$62.57 |
| J3490 |
Unclassified drugs |
58 |
38 |
$23.18 |